29-Mar-2023 - Duchenne Muscular Distrophy: the importance of microbiota as a potential target for therapeutic interventions

Duchenne muscular dystrophy (DMD) is a progressive severe muscle-wasting disease caused by mutations in DMD gene, encoding dystrophin, that leads to loss of muscle function [...]

14-Mar-2023 - GDF5: A potential treatment for (neuro)-muscular diseases

On April 19th at 2 p.m., an English-language seminar entitled “GDF5: a potential treatment for (neuro)-muscular diseases” will be held in Room 1 of the […]